Company: HRTX
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0000950170-25-105475
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-08-08
Form: 10-Q
Item: Item 1
Chunk 1
---
HERON THERAPEUTICS, INC.

Condensed Consolidated Balance Sheets

(In thousands)

     June 30,2025

     December 31,2024

     (Unaudited)

     (See Note 2)

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     16,516

     $
     25,802

     Short-term investments

     24,117

     33,481

     Accounts receivable, net

     79,931

     78,881

     Inventory, net

     72,965

     53,160

     Prepaid expenses and other current assets

     17,394

     17,690

     Total current assets

     210,923

     209,014

     Property and equipment, net

     13,683

     14,863

     Right-of-use lease assets

     1,401

     2,787

     Other assets

     6,083

     6,483

     Total assets
      
     $
     232,090

     $
     233,147

     LIABILITIES AND STOCKHOLDERS' DEFICIT

     Current liabilities:

     Accounts payable
      
     $
     12,037

     $
     11,709

     Accrued clinical and manufacturing liabilities

     17,135

     25,402

     Accrued payroll and employee liabilities

     6,471

     9,554

     Notes payable, net

     25,398

     —

     Convertible notes payable, net

     149,806

     —

     Other accrued liabilities

     46,215

     41,755

     Current lease liabilities

     1,539

     3,037

     Total current liabilities

     258,601

     91,457

     Non-current notes payable, net

     —

     25,026

     Non-current convertible notes payable, net

     —

     149,700

     Other non-current liabilities

     747

     615

     Total liabilities

     259,348

     266,798

     Stockholders' deficit:

     Common stock

     1,533

     1,521

     Additional paid-in capital

     1,890,550